Lignocaine Nebulization for Attenuation of Intubation Stress Response

NCT04441073 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Pressor Response

Interventions

DRUG: Lignocaine
DRUG: Placebo

Sponsor

Assiut University